Related Experiment Videos
Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria
Matthew E Falagas1, Ioannis A Bliziotis, Sofia K Kasiakou
1Alfa Institute of Biomedical Sciences, Athens, Greece. matthew.falagas@tufts.edu
Background:
The increasing problem of infections due to multidrug-resistant Gram-negative bacteria has led to re-use of polymyxins in several countries. However, there are already clinical isolates of Gram-negative bacteria that are resistant to all available antibiotics, including polymyxins.
Methods:
We present a case series of patients with infections due to pathogens resistant to all antimicrobial agents tested, including polymyxins. An isolate was defined as pandrug-resistant (PDR) if it exhibited resistance to all 7 anti-pseudomonal antimicrobial agents, i.e. antipseudomonal penicillins, cephalosporins, carbapenems, monobactams, quinolones, aminoglycosides, and polymyxins.
Results:
Clinical cure of the infection due to pandrug-resistant (PDR) Gram-negative bacteria, namely Pseudomonas aeruginosa or Klebsiella pneumoniae was observed in 4 out of 6 patients with combination of colistin and beta lactam antibiotics.
Conclusion:
Colistin, in combination with beta lactam antibiotics, may be a useful agent for the management of pandrug-resistant Gram-negative bacterial infections. The re-use of polymyxins, an old class of antibiotics, should be done with caution in an attempt to delay the rate of development of pandrug-resistant Gram-negative bacterial infections.
Insights
Colistin combined with beta-lactam antibiotics shows promise for treating pandrug-resistant Gram-negative bacterial infections. Careful re-use of polymyxins is crucial to combat rising antibiotic resistance.
Area of Science:
- Infectious Diseases
- Microbiology
- Pharmacology
Background:
- Rising prevalence of multidrug-resistant Gram-negative bacteria necessitates exploring alternative treatment strategies.
- Polymyxins are being re-used, but resistance to these agents is emerging.
- Pandrug-resistance (PDR) poses a critical threat, with some Gram-negative bacteria resistant to all available antibiotics.
Observation:
- A case series investigated infections caused by pandrug-resistant (PDR) Gram-negative bacteria.
- PDR isolates were defined as resistant to all 7 anti-pseudomonal antimicrobial agents.
- The study focused on pathogens like Pseudomonas aeruginosa and Klebsiella pneumoniae.
Findings:
- Combination therapy of colistin and beta-lactam antibiotics achieved clinical cure in 4 out of 6 patients.
- This combination demonstrated efficacy against PDR Gram-negative bacterial infections.
Implications:
- Colistin and beta-lactam combination therapy may be a viable option for managing PDR Gram-negative infections.
- Judicious re-use of polymyxins is essential to mitigate the further development of PDR strains.
- Further research is warranted to optimize treatment strategies for these challenging infections.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Development of Antibiotic Resistance
Clinical Significance of Antibiotic Resistance
Acute Pyelonephritis II: Diagnostic Studies and Management
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Antibiotic Selection